JORVIK GILLYGATE PRACTICE
WOOLPACK HOUSE, THE STONEBOW, YORK
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 24 | 27 | 88.9% | |
| HF 4 | 2011 | 28 | 31 | 90.3% | |
| HF 4 | 2012 | 29 | 34 | 85.3% | |
| HF 4 | 2013 | 29 | 36 | 80.6% | |
| HF004 | 2014 | 8 | 8 | 100.0% | |
| HF004 | 2015 | 8 | 11 | 72.7% | |
| HF004 | 2016 | 12 | 15 | 80.0% | |
| HF004 | 2017 | 23 | 25 | 92.0% | |
| HF004 | 2018 | 46 | 52 | 88.5% | |
| HF004 | 2019 | 46 | 58 | 79.3% | |
| HF004 | 2020 | 43 | 56 | 76.8% | |
| HF006 | 2021 | 64 | 67 | 95.5% | |
| HF006 | 2022 | 139 | 145 | 95.9% | |
| HF006 | 2023 | 132 | 139 | 95.0% |
